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Antimicrobial polypeptides are widely distributed effec-
tors of host defense in animals and plants. They include en-
zymes that digest vital microbial structures (e.g., lysozyme,
neutrophil elastase, phospholipase A2), substances that bind
and sequester iron or other essential nutrients (e.g., lacto-
ferrin), and polypeptides that insert into and disrupt micro-
bial membranes (e.g., bactericidal permeability-inducing
protein, defensins, cathelicidins; references 1 and 2). De-
spite their diverse sizes, structures, and mechanisms of ac-
tion, nearly all antimicrobial proteins and peptides have a
net cationic (positive) charge. It is thought that the electro-
static attraction of cationic polypeptides increases the depo-
sition of the polypeptides onto the negatively charged mi-
crobial surfaces and thereby promotes their effectiveness. In
support of this model, the activity of most but not all anti-
microbial polypeptides is competitively inhibited by in-
creasing the ionic strength of the medium (3–5) whose sol-
ute anions and cations shield the opposing charges of the
cationic polypeptides and anionic microbial surfaces and di-
minish their mutual attraction.
Microbes have evolved a repertoire of countermeasures
that limit the effectiveness of antimicrobial polypeptides.
Earlier clues that bacterial resistance to cationic polypep-
tides could be due to the loss of negative surface charges
came from exposing 
 
Pseudomonas fluorescens
 
 to phosphate
limitation. Under these conditions, anionic phospholipids
of bacterial membranes were largely replaced by positively
charged ornithine-modified lipids (6) and the bacteria be-
came completely resistant to the cationic peptide antibiotic
polymyxin. In other studies, acquired resistance of enteric
bacteria to the cationic antibiotic polymyxin and the anti-
microbial peptide cecropin was associated with increased
content of aminoarabinose and decreased anionic charge of
lipopolysaccharide (7, 8).
The strategy of transposon-mediated gene disruption in
pathogenic bacteria has proven particularly fruitful in iden-
tifying bacterial genes essential for bacterial survival despite
host defense. The inserted transposon allows rapid se-
quencing and identification of the disrupted gene in bacte-
rial mutants that lost resistance to host defense mechanisms.
The method identified the PhoP-PhoQ two-component
regulator of 
 
Salmonella typhimurium 
 
as an environmental
sensor and master switch that promotes survival in mac-
rophages and activates resistance to antimicrobial peptides
(9–11). Among the many processes regulated by PhoP-
PhoQ are several that covalently modify the lipid A moiety
of lipopolysaccharide and diminish its negative charge by
adding aminoarabinose, palmitate, and 2-hydroxymyristate
(12). In 
 
Staphyloccus aureus
 
, disruption of the dlt operon in-
creased bacterial susceptibility to a number of cationic
polypeptides, including human defensins human neutrophil
peptide 1–3, animal-derived protegrins, tachyplesins, and
magainin II, and even to the bacteria-derived gallidermin
and nisin (13). The dlt operon mediates the multiple steps
required for the modification of negatively charged cell
 
wall component teichoic acid by 
 
D
 
-alanine, a modification
that normally decreases the negative charge of the cell wall.
Dlt mutants bind higher amounts of cationic polypeptides
and lower amounts of a control anionic polypeptide than
the wild-type bacteria, further supporting the importance
of surface charge for bacteria–polypeptide interactions.
The study in this issue by Peschel et al. (14) provides the
most convincing evidence to date that charge modifica-
tions of bacterial membranes are an important mechanism
to decrease their vulnerability to cationic polypeptides. By
transposon mutagenesis in 
 
Staphyloccus xylosus
 
, Peschel et
al. identified a gene, 
 
mprF
 
, that conferred resistance to the
cationic peptide antibiotic gallidermin. The homologous
 
S. aureus
 
 
 
mprF 
 
mutant showed at least 8–30-fold higher
susceptibility to human neutrophil defensin, porcine neu-
trophil protegrins, and horseshoe crab hemocyte peptide
tachyplesin and bound much more cationic peptide than
the wild-type. Comparison of the lipid composition of the
wild-type and 
 
mprF
 
 strains revealed a dramatic change: the
major membrane lipid lysylphosphatidylglycerol was lost in
the mutant but could be restored by complementation
with the
 
 mprF 
 
gene. Lysylphosphatidylglycerol results from
 
the addition of the cationic amino acid lysine to the
anionic phospholipid phosphatidylglycerol, the principal
phospholipid of the 
 
S. aureus
 
 membrane (15, 16). In the
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wild-type, this modification changes the net charge of up
to 38% of phosphatidylglycerol from negative to positive.
The shear magnitude of this effect, involving the major
components visible on paper chromatograms of bacterial
lipids, suggests that this is a critically important bacterial
adaptation. It is notable that artificial membranes com-
posed of unmodified phosphatidylglycerol are particularly
vulnerable to cationic antimicrobial peptides (17).
The 
 
mprF
 
 lesion affected the susceptibility of the mutant
to host defense mechanisms and its pathogenicity. The
 
mprF
 
 mutant was killed much faster than wild-type 
 
S. au-
reus
 
 by human neutrophils and was less virulent in the
mouse models of sepsis and septic arthritis. The 
 
mprF 
 
defect
was specific for cationic polypeptides since the mutant bac-
teria had unchanged susceptibility to reactive oxygen inter-
mediates generated by the myeloperoxidase–hydrogen per-
oxide–chloride system, or to the uncharged antibiotic
gramicidin. The proposed role of 
 
mprF
 
 in the bacterial arse-
nal of countermeasures is further supported by its location
near other genes implicated in microbial resistance. Unfor-
tunately, the neighbors or the structure of 
 
mprF 
 
itself give
no clues to its specific function. The gene encodes a large
membrane protein with homologues in other bacteria
pathogenic in plants and animals. It will be important to
determine whether the mprF protein is the lysylphosphati-
dylglycerol synthase or if it supplies an essential synthetic
intermediate, or exerts a regulatory function. Until then,
caution is required in attributing the pathogenic effect of
the gene solely to lysylation of phosphatidylglycerol and its
effects on bacterial surface charge.
 
S. aureus
 
 has much more lysylphosphatidylglycerol than
other less pathogenic 
 
Staphylococci 
 
(18). This raises the ques-
tion of whether the relatively small amounts of this lipid in
 
S. xylosus
 
 account for its resistance to gallidermin compared
with the 
 
mprF
 
 mutant, or if additional mechanisms contrib-
ute. Conversely, as suggested by the authors, the large
amounts of lysylphosphatidylglycerol in 
 
S. aureus
 
 may se-
lectively protect it in such cationic polypeptide-rich niches
as nasal fluid (19) or inflamed skin (20).
Surface charge modifications are not the only mecha-
nisms that contribute to resistance of bacteria to antimicro-
bial polypeptides. Some bacteria employ proteases to digest
and inactivate antimicrobial polypeptides (21). PgtE, a
posttranscriptionally regulated outer membrane protease of
 
S. typhimurium,
 
 is also induced by the PhoP-PhoQ system,
and degrades 
 
a
 
-helical antimicrobial peptides but not the
more protease-resistant 
 
b
 
-sheet containing defensins or
protegrins.
 
 Neisseria gonorhoeae
 
, a pathogen well known for
its ability to survive in neutrophil-rich environments, em-
ploys an efflux system, mtr, that removes various structur-
ally unrelated antimicrobial substances from exposed bacte-
ria. Protegrins and LL-37, abundant cationic peptides of
porcine and human neutrophils, respectively (22), are par-
tially neutralized by the mtr system. Bacteria with disabled
mtr efflux are 
 
z
 
10-fold more sensitive to protegrin than
wild-type strains and accumulate substantially higher
amounts of the peptide. Peptide removal is blocked by pro-
ton ionophores that depolarize the bacterial cytoplasmic
 
membrane and is restored by glucose, indicating that it is an
energy-dependent process.
Although the specific mechanisms of resistance to cat-
ionic polypeptides have been described in a small number
of laboratory bacterial strains, they are widely distributed
with homologues of the resistance genes already identified
in many pathogenic bacteria. If the emerging view of the
biological role of these mechanisms is correct, many of the
bacterial resistance mechanisms will lack mammalian coun-
terparts and could be pharmacologically inhibited without
adverse effects on the host. The bacterial countermeasures
to host defense mechanisms may yet prove to be the Achil-
les’ heel of pathogens increasingly refractory to conven-
tional antibiotics.
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